Japan's NGK Licenses OGT's Oligo IP to Develop, Sell Microarrays | GenomeWeb
NEW YORK (GenomeWeb News) – Japan’s NGK Insulators has licensed from Oxford Gene Technology patents for oligonucleotide microarrays in order to manufacture its own arrays, OGT said today.
 
The Japanese company will make the arrays using a technology called Geneshot, which uses piezoelectric ceramic microactuators. NGK can sell these OEM and NGK-branded microarrays in Japan.
 
The license will remain valid for the patents’ lifetime.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.